SENS

MKT CAP:$298M

Senseonics Holdings, Inc.

Market Cap

$298M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$6.88+$0.99 (+16.81%)

Apr 22, 2026

Company Details

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products incl...

CEO

Timothy T. Goodnow

IPO Date

Dec 22, 2015

Website

www.senseonics.com

Key Metrics TTM

Revenue

$27M

+12.0% YoY

Net Income

-$73M

EPS (Diluted)

-$2.06

Free Cash Flow

-$61M

Revenue / Share

$0.60

Gross Margin

18.1%

Operating Margin

-260.9%

Net Margin

-272.1%

FCF Margin

-228.1%

P/S

11.1x

P/E

—

Earnings Reports

Q4 2025

May 14, 2026

PENDING

FY 2025

Mar 2, 2026

$35M+56.9%EPS -$1.66

Q3 2025

Nov 5, 2025

$8M+89.9%EPS -$0.43

Q1 2025

May 8, 2025

$6M+24.0%EPS -$0.40

FY 2024

Mar 3, 2025

$22M+0.4%EPS -$2.50

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$4M	-$1M	-$16M
Q4 21	$4M	-$483.0K	-$14M
Q1 22	$2M	$527.0K	-$15M
Q2 22	$4M	$824.0K	-$17M
Q3 22	$5M	$756.0K	-$18M
Q4 22	$6M	$619.0K	-$19M
Q1 23	$4M	$414.0K	-$20M
Q2 23	$4M	$417.0K	-$20M
Q3 23	$6M	$1M	-$19M
Q4 23	$8M	$1M	-$17M
Q1 24	$5M	$335.0K	-$18M
Q2 24	$5M	$298.0K	-$19M
Q3 24	$4M	-$4M	-$23M
Q4 24	$8M	$4M	-$14M
Q1 25	$6M	$2M	-$13M
Q3 25	$8M	$3M	-$20M

Valuation

Quarter	P/S	P/E
Q3 21	22.0x	—
Q4 21	21.8x	—
Q1 22	22.4x	8.8x
Q2 22	21.7x	0.9x
Q3 22	20.1x	1.4x
Q4 22	18.2x	2.1x
Q1 23	16.5x	5.2x
Q2 23	16.1x	—
Q3 23	14.9x	—
Q4 23	13.3x	—
Q1 24	12.8x	—
Q2 24	12.4x	—
Q3 24	13.4x	—
Q4 24	13.3x	—
Q1 25	12.6x	—
Q3 25	11.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	-$14M	-$14M
Q4 21	-$12M	-$12M
Q1 22	-$20M	-$20M
Q2 22	-$14M	-$14M
Q3 22	-$15M	-$15M
Q4 22	-$17M	-$17M
Q1 23	-$20M	-$20M
Q2 23	-$18M	-$18M
Q3 23	-$17M	-$17M
Q4 23	-$15M	-$15M
Q1 24	-$20M	-$21M
Q2 24	-$11M	-$13M
Q3 24	-$15M	-$15M
Q4 24	-$14M	-$14M
Q1 25	-$16M	-$17M
Q3 25	-$16M	-$16M

Capital Expenditures

Quarter	CapEx
Q3 21	$28.0K
Q4 21	$135.0K
Q1 22	$137.0K
Q2 22	$74.0K
Q3 22	$44.0K
Q4 22	$57.0K
Q1 23	$57.0K
Q2 23	$0
Q3 23	$123.0K
Q4 23	$170.0K
Q1 24	$316.0K
Q2 24	$2M
Q3 24	$203.0K
Q4 24	$34.0K
Q1 25	$434.0K
Q3 25	$164.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+360.5%	+47.8%
Q4 21	+3.2%	+26.5%
Q1 22	-12.8%	+24.6%
Q2 22	+12.9%	+8.2%
Q3 22	+30.9%	+13.4%
Q4 22	+39.0%	+36.1%
Q1 23	+66.7%	+35.2%
Q2 23	+11.1%	+15.6%
Q3 23	+31.9%	+13.2%
Q4 23	+44.1%	+2.5%
Q1 24	+22.0%	-2.4%
Q2 24	+17.9%	+1.5%
Q3 24	-30.1%	+7.9%
Q4 24	+3.3%	-9.9%
Q1 25	+24.0%	-15.2%
Q3 25	+66.4%	+13.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$2M	68.3%
Q4 21	$2M	47.3%
Q1 22	$2M	70.0%
Q2 22	$3M	69.6%
Q3 22	$2M	48.1%
Q4 22	$2M	37.2%
Q1 23	$2M	43.1%
Q2 23	$3M	69.6%
Q3 23	$2M	34.2%
Q4 23	$2M	24.1%
Q1 24	$2M	35.7%
Q2 24	$3M	60.1%
Q3 24	$2M	57.1%
Q4 24	$2M	24.9%
Q1 25	$2M	29.4%
Q3 25	$3M	34.5%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	$7M	$5M	$2M	—
Q4 21	$8M	$4M	$2M	—
Q1 22	$8M	$6M	$2M	—
Q2 22	$9M	—	—	$9M
Q3 22	$11M	—	—	$7M
Q4 22	$12M	—	—	$8M
Q1 23	$12M	—	—	$8M
Q2 23	$13M	—	—	$7M
Q3 23	$13M	—	—	$7M
Q4 23	$11M	—	—	$7M
Q1 24	$10M	—	—	$8M
Q2 24	$11M	—	—	$9M
Q3 24	$11M	—	—	$8M
Q4 24	$9M	—	—	$9M
Q1 25	$7M	—	—	$8M
Q3 25	$8M	—	—	$15M

Revenue by Geography

Quarter	Non-US	United States
Q3 25	$2M	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$39M	$103M	$142M
Q2 22	$45M	$94M	$139M
Q3 22	$35M	$119M	$154M
Q4 22	$36M	$108M	$144M
Q1 23	$45M	$83M	$128M
Q2 23	$29M	$89M	$118M
Q3 23	$56M	$70M	$125M
Q4 23	$76M	$34M	$109M
Q1 24	$91M	$8M	$99M
Q2 24	$35M	$50M	$85M
Q3 24	$27M	$47M	$74M
Q4 24	$75M	$0	$75M
Q1 25	$39M	$25M	$64M
Q2 25	$32M	$95M	$126M
Q3 25	$35M	$76M	$111M
Q4 25	$41M	$54M	$94M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	29M	+34.7%	+146.0%
Q4 21	22M	-23.2%	+88.9%
Q1 22	30M	+35.4%	+66.1%
Q2 22	30M	-0.6%	+39.2%
Q3 22	24M	-21.4%	-18.8%
Q4 22	34M	+45.8%	+54.2%
Q1 23	27M	-21.6%	-10.7%
Q2 23	28M	+4.9%	-5.7%
Q3 23	30M	+4.5%	+25.4%
Q4 23	27M	-10.5%	-23.0%
Q1 24	31M	+15.9%	+13.7%
Q2 24	31M	+0.3%	+8.7%
Q3 24	31M	+0.7%	+4.8%
Q4 24	33M	+7.4%	+25.7%
Q1 25	36M	+7.8%	+17.0%
Q3 25	45M	+25.1%	+45.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$43.1K	82
Q4 21	$45.0K	89
Q1 22	$27.9K	89
Q2 22	$41.7K	89
Q3 22	$51.9K	89
Q4 22	$43.5K	128
Q1 23	$32.3K	128
Q2 23	$32.2K	128
Q3 23	$47.6K	128
Q4 23	$60.8K	132
Q1 24	$38.2K	132
Q2 24	$36.9K	132
Q3 24	$32.3K	132
Q4 24	$70.9K	117
Q1 25	$53.5K	117
Q3 25	$69.2K	117

Revenue / Employee